GlycoNex (ROCO:4168) Short Interest


ROCO:4168 GlycoNex Inc ROCO:4168
56 GF Score
Price NT$25.60
GF Value NT$74.21
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is GlycoNex Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ROCO:4168 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, GlycoNex's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlycoNex Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlycoNex's Short Interest distribution charts can be found below:

* The bar in red indicates where GlycoNex's Short Interest falls into.


ROCO:4168
56GF Score
GlycoNex Inc ROCO:4168
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GlycoNex (ROCO:4168) Overvalued in 2026?

Based on GuruFocus' analysis, GlycoNex stock appears to be undervalued. The current stock price of NT$25.60 is trading 65.5% below its estimated GF Value™ of NT$74.21. GuruFocus considers GlycoNex to be Significantly Undervalued.

Key valuation signals for ROCO:4168:

  • Short Interest:
  • GF Value™: NT$74.21 vs. price of NT$25.60 (65.5% below fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GlycoNex Business Description

Address Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221
GlycoNex Inc is a Taiwan-based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The other services provided by the firm include functional evaluation, antibody research, and antibody engineering. It has two reportable segments: antibody new drug, which derives maximum revenue, and exclusive investment. Geographically, the group derives maximum revenue from Taiwan and the rest from Japan.
56GF Score

Get the complete analysis for ROCO:4168

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.60
Price
NT$74.21
GF Value